BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen R, Pan S, Lai K, Lai LA, Crispin DA, Bronner MP, Brentnall TA. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer. World J Gastroenterol 2014; 20(45): 17037-17048 [PMID: 25493016 DOI: 10.3748/wjg.v20.i45.17037]
URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17037.htm
Number Citing Articles
1
Abdullah Hoter, Hassan Y. Naim. The Functions and Therapeutic Potential of Heat Shock Proteins in Inflammatory Bowel Disease—An UpdateInternational Journal of Molecular Sciences 2019; 20(21): 5331 doi: 10.3390/ijms20215331
2
Hong-Yuan Tsai, Mary P. Bronner, Jordon K. March, John F. Valentine, Noah F. Shroyer, Lisa A. Lai, Teresa A. Brentnall, Sheng Pan, Ru Chen. Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancerCancer Letters 2022; 549: 215915 doi: 10.1016/j.canlet.2022.215915
3
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz A. Bromke, Katarzyna Neubauer. Oxidative Stress Markers in Inflammatory Bowel Diseases: Systematic ReviewDiagnostics 2020; 10(8): 601 doi: 10.3390/diagnostics10080601
4
Ping Han, Qing-Ling Wang, Xia Zhang. Expression of TRAP1 in gastric cancer tissue and its correlation with malignant biologyAsian Pacific Journal of Tropical Medicine 2016; 9(1): 67 doi: 10.1016/j.apjtm.2015.12.014
5
Van‐An Duong, Altai Enkhbayar, Nobel Bhasin, Lakmini Senavirathna, Eva C. Preisner, Kristi L. Hoffman, Richa Shukla, Robert R. Jenq, Kai Cheng, Mary P. Bronner, Daniel Figeys, Robert A. Britton, Sheng Pan, Ru Chen. A complementary metaproteomic approach to interrogate microbiome cultivated from clinical colon biopsiesPROTEOMICS 2024;  doi: 10.1002/pmic.202400078
6
Abhinav Joshi, Takeshi Ito, Didier Picard, Len Neckers. The Mitochondrial HSP90 Paralog TRAP1: Structural Dynamics, Interactome, Role in Metabolic Regulation, and InhibitorsBiomolecules 2022; 12(7): 880 doi: 10.3390/biom12070880
7
Ting Zhao, Xianmin Mu, Qiang You. Succinate: An initiator in tumorigenesis and progressionOncotarget 2017; 8(32): 53819 doi: 10.18632/oncotarget.17734
8
Chang-Ho Ryan Choi, Ibrahim Al-Bakir. Biomarkers in Inflammatory Bowel Diseases2019; : 155 doi: 10.1007/978-3-030-11446-6_13
9
Min Gyoung Pak, Hyong Jong Koh, Mee Sook Roh. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissuesDiagnostic Pathology 2017; 12(1) doi: 10.1186/s13000-017-0598-3
10
Sang Hyoung Park, Myunghee Hong, Ho‐Su Lee, Byong Duk Ye, Sung Wook Hwang, Seulgi Jung, Jiwon Baek, Jung Won Moon, Byoung Mok Kim, Seak Hee Oh, Kyung Mo Kim, Inchul Lee, Chang‐Nim Im, Jianjun Liu, Dermot P B McGovern, Suk‐Kyun Yang, Kyuyoung Song. Association of TRAP1 with infliximab‐induced mucosal healing in Crohn's diseaseJournal of Gastroenterology and Hepatology 2019; 34(12): 2118 doi: 10.1111/jgh.14696
11
Yuyi Yuan, Hui Wu, Bo Shuai, Chang Liu, Feng Zhu, Fei Gao, Chunzhu Wei, Heng Fan. Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophora DecoctionCurrent Pharmaceutical Design 2022; 28(42): 3456 doi: 10.2174/1381612829666221122113929
12
Bo Zhang, Jing Wang, Zhen Huang, Peng Wei, Ying Liu, Junfeng Hao, Lijing Zhao, Fenglin Zhang, Yaping Tu, Taotao Wei. Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancerOncotarget 2015; 6(42): 44495 doi: 10.18632/oncotarget.6252
13
Angela-Maria Merli, Sophie Vieujean, Charlotte Massot, Noella Blétard, Florence Quesada Calvo, Dominique Baiwir, Gabriel Mazzucchelli, Laurence Servais, Odile Wéra, Cécile Oury, Laurence de Leval, Christine Sempoux, Roberto Manzini, Sena Bluemel, Michael Scharl, Gerhard Rogler, Edwin De Pauw, C Coimbra Marques, Arnaud Colard, Anne Vijverman, Philippe Delvenne, Edouard Louis, Marie-Alice Meuwis. Solute Carrier Family 12 Member 2 as a Proteomic and Histological Biomarker of Dysplasia and Neoplasia in Ulcerative ColitisJournal of Crohn's and Colitis 2021; 15(2): 287 doi: 10.1093/ecco-jcc/jjaa168
14
Ionica Masgras, Claudio Laquatra, Giuseppe Cannino, Stefano A. Serapian, Giorgio Colombo, Andrea Rasola. The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targetingSeminars in Cancer Biology 2021; 76: 45 doi: 10.1016/j.semcancer.2021.07.002
15
Yuchu Xiang, Xudong Liu, Qi Sun, Kuo Liao, Xiaohan Liu, Zihui Zhao, Lishuang Feng, Yan Liu, Bo Wang. The development of cancers research based on mitochondrial heat shock protein 90Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1296456
16
Chang Gao, Min Li, An‑Li Jiang, Rui Sun, Hong‑Lin Jin, Hua‑Wei Gui, Fei Xiao, Xiang‑Wu Ding, Zhen‑Ming Fu, Jue‑Ping Feng. Overexpression of the mitochondrial chaperone tumor necrosis factor receptor‑associated protein 1 is associated with the poor prognosis of patients with colorectal cancerOncology Letters 2018;  doi: 10.3892/ol.2018.8042
17
Ru Chen, Lisa A Lai, Teresa A Brentnall, Sheng Pan. Biomarkers for colitis-associated colorectal cancerWorld Journal of Gastroenterology 2016; 22(35): 7882-7891 doi: 10.3748/wjg.v22.i35.7882
18
Bincy P. Abraham. Cancer surveillance in ulcerative colitis and Crohnʼs diseaseCurrent Opinion in Gastroenterology 2016; 32(1): 32 doi: 10.1097/MOG.0000000000000234
19
Mimmo Turano, Rosario Vicidomini, Francesca Cammarota, Valeria D’Agostino, Francesca Duraturo, Paola Izzo, Marina De Rosa. The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate AccumulationBiomedicines 2023; 11(5): 1428 doi: 10.3390/biomedicines11051428
20
Francesca Maddalena, Vittorio Simeon, Giulia Vita, Annamaria Bochicchio, Luciana Possidente, Lorenza Sisinni, Giacomo Lettini, Valentina Condelli, Danilo Swann Matassa, Valeria Li Bergolis, Alberto Fersini, Sante Romito, Michele Aieta, Antonio Ambrosi, Franca Esposito, Matteo Landriscina. TRAP1 protein signature predicts outcome in human metastatic colorectal carcinomaOncotarget 2017; 8(13): 21229 doi: 10.18632/oncotarget.15070